KFF October 23, 2024

Costs are limiting states’ coverage of obesity drugs and could affect other Medicaid priorities

States expect national Medicaid enrollment to decline by about 4% and state Medicaid spending to rise by 7% in fiscal year (FY) 2025. These rates follow a larger but anticipated enrollment decline and state spending increase in FY 2024, as pandemic-era policies and federal funding expired, according to KFF’s 24th annual survey of state Medicaid directors.

While state fiscal conditions remain stable heading into FY 2025, the longer-term fiscal and policy outlook for Medicaid programs is less certain. Reduced state revenue collections, the expiration of pandemic-era federal funding, and macroeconomic uncertainties, may discourage states from increasing funding for access to behavioral health, long-term services and supports,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Insurance, Medicaid, States
Resumption Of Medicaid Eligibility Redeterminations: Little Change In Overall Insurance Coverage
Medicaid Enrollment & Spending Growth: FY 2024 & 2025
As Pandemic-Era Policies End, Medicaid Programs Focus on Enrollee Access and Reducing Health Disparities Amid Future Uncertainties: Results from an Annual Medicaid Budget Survey for State Fiscal Years 2024 and 2025
US Medicaid Programs Say Cost a Key Factor for Weight-loss Drug Coverage, Survey Finds
More state Medicaid programs consider covering GLP-1 drugs

Share This Article